Solvent-based delamination and selective dissolution technology for recycling complex bio-based multilayer packaging films. Enables separation of bonded polymer layers into individual recyclable films, supporting circular economy goals in sustainable packaging with low energy input and minimal greenhouse gas emissions.
Multilayer packaging films deliver superior product protection by combining the unique properties of multiple polymers and additives, but their tightly bonded structures make recycling extremely difficult. This research program targets the recycling of bio-based multilayer packaging through a two-stage approach: solvent-driven delamination of bonded layers into individual films, followed by selective dissolution to separate and recover the constituent polymers for reprocessing into new products. The approach is designed to be energy-efficient and low in greenhouse gas emissions because it preserves most of the polymer content in its original state with minimal degradation.
The research team has demonstrated proof-of-concept delamination of conventional multilayer films, including PE/PET, LLDPE/Nylon 6, LLDPE/EVOH, and HDPE/EVOH combinations, using a variety of solvents. They have also achieved separation of similar polymer mixtures such as polyolefins via selective dissolution. This expertise is now being extended to bio-based multilayer packaging systems containing polymers such as PLA and PHA.
Delamination approach:
Polymer separation and recovery:
Key advantages:
The technology is at an early-to-mid stage of development. Delamination of conventional multilayer film systems has been demonstrated in laboratory settings, and separation of similar polymer mixtures via selective dissolution has been achieved. Extension to bio-based multilayer packaging is the current focus, with ongoing work targeting PLA- and PHA-containing films. Future validation steps include demonstrating hybrid delamination and separation techniques, evaluating recovered polymer properties, and developing solvent recovery processes for scale-up. The approach is ready for collaborative research partnerships to advance toward pilot-scale validation.
University at Buffalo is a comprehensive public research university and a leading campus in the State University of New York system. Industry engagement is anchored by co-located labs on a downtown medical campus, a research and technology park with incubators, shared core facilities, and co-op talent pipelines. Partnerships with regional hospitals enable clinical studies and translation, while proximity to the U.S.–Canada border and the binational Great Lakes corridor facilitates cross‑border collaboration. Research is supported by competitive federal funding from NIH, NSF, DOE, and DoD, alongside New York State innovation programs. A dedicated technology transfer office provides IP management, licensing, and startup support.